-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
NRX Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2017 to Q1 2024.
- NRX Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
- NRX Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was $17.8K, a 78.8% decline from 2019.
- NRX Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2019 was $84.2K, a 416% increase from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)